Professor of Neurological Surgery
University of Washington
Seattle, Washington, United States
Dr. Samuel R. Browd, M.D., Ph.D., FACS, FAANS, FAAP is Professor of Neurological Surgery at the University of Washington and Attending Neurosurgeon at Seattle Children’s Hospital. Dr. Browd is the Founding Director of the UW Institute 83B (Computation Neurosurgery Institute), Director of The Sports Institute at UW Medicine and Medical Director of the Seattle Children’s Sports Concussion Program. Dr. Browd also serves as Seattle Children’s Neurosurgical Director of the Tone Management Program and Pediatric Complex Spine. Dr. Browd is adjunct Professor of Bioengineering and affiliate faculty of the Foster School of Business. Dr. Browd serves as an Unaffiliated Neurologic Consultant to the NFL and as an independent neurologic consultant to the Seattle Seahawks. Dr. Browd completed a combined M.D. and Ph.D at the University of Florida studying neuroplasticity and learning and his current research interests include robotics and computational healthcare. Dr. Browd has co-founded multiple venture backed medtech start-up where he served various roles including CEO and chief medical officer including Proprio, VICIS, Aqueduct Neuroscience, Navisonics, AllCylinders, Deepwell and Neufluent. Dr. Browd also serves as a business and medical advisor to numerous early-stage biotech companies and venture capital firms. Dr. Browd was a UW Presidential Entrepreneurial Faculty Fellow and teaches at the UW Foster School of Business, he also lectures internationally on biomedical innovation and commercialization. Dr. Browd was recognized as the University of Washington School of Medicine Inventor of the Year in 2016 and co-developed three products that were listed as Time Magazine’s Invention of the Year in 2017, 2019, 2022. Dr. Browd was honored to be the 2021 Congress of Neurological Surgeons Innovator of the Year.
Disclosure(s): Neufluent: Board Member/Officer/Trustee (Ongoing), Ownership Interest (Ongoing); ProprioVision: Board Member/Officer/Trustee (Ongoing), Ownership or Partnership (Ongoing)
Introduction of Cushing Orator
Sunday, May 5, 2024
11:37 AM – 11:40 AM CT
The Future of AI in Neurosurgery: Panel Discussion (non-CME)
Sunday, May 5, 2024
4:15 PM – 5:00 PM CT